INFORMATION

Active Ingredient: Lastlerge is the FIRST & ONLY Mizolastine in Egypt introduced in market, H1 2nd generation Antihistamine , long acting & non-sedating approved by EMA in treating Allergic Rhinoconjunctivitis and Urticaria in 1996 Indications: Lastlerge 10mg used in adult including elderly and children 12 years of age and over (once daily dose) . pack: Lastlerge available in a pack of 14 tablets.

Lastlerge ER Tab.

Lastlerge ER Tab.

Perfect Partner

Lastlerge ER Tab.

• - H1 2nd generation Antihistamine
• - elderly and children 12 years of age and over
• - 14 tablets.

Lastlerge ER Tab.

Active Ingredient: Lastlerge is the FIRST & ONLY Mizolastine in Egypt introduced in market, H1 2nd generation Antihistamine , long acting & non-sedating approved by EMA in treating Allergic Rhinoconjunctivitis and Urticaria in 1996 Indications: Lastlerge 10mg used in adult including elderly and children 12 years of age and over (once daily dose) . pack: Lastlerge available in a pack of 14 tablets.